Clinical Trials Browser

Phase 2 × Gastrointestinal Neoplasms × Capecitabine × Clear all

NCT03929666 2025-09-12

A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer

Phase 2 Completed

Gastrointestinal

Biliary Tract Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

NCT05494060 2023-11-07

EXPLORING

Phase 2 Recruiting

Gastrointestinal

Carcinoma, Digestive System Diseases, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Stomach Neoplasms

NCT01845337 2023-05-12

TOFFEE

Phase 2 Completed

Gastrointestinal

Bile Duct Neoplasms, Gastrointestinal Neoplasms, Neoplasms, Unknown Primary, Pancreatic Neoplasms

NCT04080843 2022-07-13

ALTER-C-002

Phase 2 Completed

Gastrointestinal

Colonic Diseases, Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Neoplasms, Neoplasms by Site, Rectal Diseases, Colorectal Neoplasms

NCT02595320 2021-12-20

X7-7

Phase 2 Unknown

BreastGastrointestinal

Breast Neoplasms, Gastrointestinal Neoplasms, Neoplasm Metastasis, Neoplasms

NCT01129310 2019-02-25

IXOGoo1

Phase 2 Completed

Gastrointestinal

Gastrointestinal Neoplasms

NCT02216149 2018-08-28

FluoHeart

Phase 2 Terminated

Gastrointestinal

Colonic Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Rectal Neoplasms, Stomach Neoplasms